Literature DB >> 9220669

Transmission of the agent of human granulocytic ehrlichiosis by host-seeking Ixodus scapularis (Acari:Ixodidae) in southern New York state.

F Des Vignes1, D Fish.   

Abstract

Ixodes scapularis Say nymphs collected from a natural focus of human granulocytic ehrlichiosis (HGE) in Westchester County, New York, transmitted the HGE agent to uninfected mice in the laboratory. Infection was demonstrated in 3 of 8 mice by polymerase chain reaction analysis of whole blood and microscopic examination of blood smears for morulae. Two of these mice were also positive by xenodiagnosis. Positive xenodiagnostic larvae maintained infection through molting and transferred infection to 1 of 3 mice. Naturally infected I. scapularis ticks transmit the agent of human granulocytic ehrlichiosis to mice, but both acquisition and transmission of this agent by I. scapularis appear to be less efficient than would be expected for Borrelia burgdorferi Johnson, Schmid, Hyde, Steigerwalt & Brenner, the agent of Lyme disease.

Entities:  

Mesh:

Year:  1997        PMID: 9220669     DOI: 10.1093/jmedent/34.4.379

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  21 in total

1.  Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data.

Authors:  F Scott Dahlgren; Kristen Nichols Heitman; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

2.  Molecular characterization of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes scapularis ticks from Pennsylvania.

Authors:  Joshua W Courtney; Richard L Dryden; Jill Montgomery; Bradley S Schneider; Gary Smith; Robert F Massung
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.

Authors:  Cynthia M Tate; Daniel G Mead; M Page Luttrell; Elizabeth W Howerth; Vivien G Dugan; Ulrike G Munderloh; William R Davidson
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks.

Authors:  Y F Chang; S P McDonough; C F Chang; K S Shin; W Yen; T Divers
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

Review 5.  Ticks feeding on humans: a review of records on human-biting Ixodoidea with special reference to pathogen transmission.

Authors:  A Estrada-Peña; F Jongejan
Journal:  Exp Appl Acarol       Date:  1999-09       Impact factor: 2.132

6.  Infection with agents of human granulocytic ehrlichiosis, lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut.

Authors:  K C Stafford; R F Massung; L A Magnarelli; J W Ijdo; J F Anderson
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Undetermined Human Ehrlichiosis and Anaplasmosis in the United States, 2008-2012: A Catch-All for Passive Surveillance.

Authors:  F Scott Dahlgren; Kristen Nichols Heitman; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

8.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Disparity in the natural cycles of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis.

Authors:  M L Levin; F des Vignes; D Fish
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.